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ABSTRACT
Nuclear factors NF90 and NF45 form a complex
involved in a variety of cellular processes and are
thought to affect gene expression both at the tran-
scriptional and translational level. In addition, this
complex affects the replication of several viruses
through direct interactions with viral RNA. NF90
and NF45 dimerize through their common ‘DZF’
domain (domain associated with zinc fingers).
NF90 has additional double-stranded RNA-binding
domains that likely mediate its association with
target RNAs. We present the crystal structure of
the NF90/NF45 dimerization complex at 1.9-A˚ reso-
lution. The DZF domain shows structural similarity
to the template-free nucleotidyltransferase family of
RNA modifying enzymes. However, both NF90 and
NF45 have lost critical catalytic residues during evo-
lution and are therefore not functional enzymes.
Residues on NF90 that make up its interface with
NF45 are conserved in two related proteins,
spermatid perinuclear RNA-binding protein (SPNR)
and zinc-finger RNA-binding protein (Zfr). Using a
co-immunoprecipitation assay and site-specific
mutants, we demonstrate that NF45 is also able to
recognize SPNR and Zfr through the same binding
interface, revealing that NF45 is able to form a
variety of cellular complexes with other DZF-
domain proteins.
INTRODUCTION
Nuclear factors NF90 (also known as ILF3, DRBP76 or
NFAR-1) and NF45 (also known as ILF2) form a protein
complex that regulates gene expression at multiple levels
(1,2). The complex was ﬁrst identiﬁed as a transcrip-
tion factor involved in IL-2 transcription in activated
T-cells (3,4). Subsequently the NF90/NF45 complex has
been identiﬁed in a number of different contexts. For
example, NF90/NF45 has been implicated in DNA
binding, transcription and repair, although it does not
contain classical DNA-binding domains (3,5–8). On the
other hand, NF90 contains classical double-stranded
RNA-binding domains (dsRBDs) and is proposed to
play a role in gene expression at the RNA level, either
through direct association with mRNAs or through re-
pression of miRNA metabolism (9–15).
In addition to its normal cellular roles, NF90/NF45
plays a critical role in the life cycle of several viruses,
such as Hepatitis C virus (HCV), Bovine Viral
Diarrhoea Virus (BVDV), Dengue virus and human im-
munodeﬁciency virus (HIV) that have a global impact on
human and animal health (13,16–19). In the case of
plus-stranded RNA viruses such as HCV and Dengue
virus, NF90/NF45 is thought to associate with the viral
genomic RNA through regulatory RNA structures in the
50- and 30-non-translated regions and has been observed to
co-localize with viral replication foci in the cytoplasm
(18,19). Plus-stranded RNA viral genomes resemble
cellular mRNAs and it is possible that a normal cellular
role of NF90/NF45 is co-opted by the viruses to further
their own ends. Indeed, in the case of HIV, NF90 impacts
on viral replication by modulating translation of Cyclin
T1 through association with the 30-untranslated region of
Cyclin T1 mRNA (13). Knock-down of NF90 causes a
shift of Cyclin T1 mRNA from polysomes to monosomes
and the consequent reduction in Cyclin T1 protein reduces
HIV proliferation.
NF90/NF45 has been shown to bind to several speciﬁc
mRNAs other than Cyclin T1, including MKP-1, IL-2,
acid b-glucosidase and to affect either translation or
turnover of these mRNAs (9,11,15). Global RNA
immunoprecipitation studies on the other hand, have
shown that the complex can associate with a wide
variety of mRNAs and non-coding RNAs (12,14,20).
Together, these studies indicate a role for NF90/NF45 in
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post-transcriptional control of gene expression. However,
what motifs are recognized by NF90/NF45 and what the
molecular consequences are of NF90/NF45 association
with mRNAs are not yet well understood. Clearly, a
better understanding of the molecular role of this
complex would provide valuable insights into its
function both in viral infection and in normal cellular
processes.
NF90 is found only in vertebrates while NF45 is found
throughout the metazoa. In mammals, NF90 and NF45
show a broad tissue distribution but are particularly
abundant in brain, spleen, testes and liver (14,21,22).
Although NF90 and NF45 are nominally nuclear
factors, the protein complex has been shown to shuttle
between the nucleus and cytoplasm and certain splice
variants of NF90 are preferentially located in the cyto-
plasm in normal tissue (14,15).
NF90 has a domain architecture that consists of an
N-terminal domain with no known function, called a
‘domain associated with zinc ﬁngers’ or DZF domain.
This domain is followed by two dsRBDs and a
low-complexity region at the C-terminus. The C-terminal
region is the site of most sequence variations generated by
alternative splicing and longer splice variants of NF90
show an enrichment of arginine, glycine and serine
residues in this region (23). The DZF domain is found
in three other proteins, namely NF45, spermatid peri-
nuclear RNA-binding protein (SPNR, also known as
STRBP) and Zinc-finger protein associated with RNA
(Zfr). SPNR is a testes-speciﬁc paralogue of NF90 that
has a similar domain organization while Zfr, an essential
gene in mice and ﬂies, has a different domain organiza-
tion. In Zfr the DZF domain is found at the C-terminus
and is preceded by several RNA-binding zinc ﬁngers.
NF45, the partner of NF90, is much smaller than the
other proteins in the family. The DZF domain of NF45
is the only folded domain present in the protein sequence
and is ﬂanked by an arginine- and glycine-rich sequence at
the N-terminus and a glutamate-rich sequence at the
C-terminus (Figure 1A).
While NF90/NF45 is thought to have a role in many
aspects of gene expression and RNA metabolism, the mo-
lecular mechanisms responsible for these various processes
are poorly understood. One possibility is that the dsRBDs
of NF90 might direct the complex to its RNA targets,
although the speciﬁcity of such an interaction remains un-
deﬁned. Furthermore, the DZF domain is thought to
mediate dimerization of NF90 with NF45 but any
further role that this domain might have is not known.
To gain insight into the possible function of NF90/
NF45, we have solved the crystal structure of a truncated
complex that contains the DZF dimerization domains.
Our work demonstrates that the DZF domain has
evolved from a family of RNA metabolizing enzymes.
Based on the conservation of the NF90 dimer interface,
we were able to identify other putative binding partners of
NF45. We demonstrate, using a cell-based assay that
NF45 can dimerize with other DZF-domain containing
proteins through a structurally conserved interface. This
ﬁnding suggests that NF45 may have a previously
unappreciated role in other complexes that are involved
in RNA metabolism.
MATERIALS AND METHODS
Puriﬁcation of NF90/NF45 constructs
Mouse cDNAs for NF90 and NF45 were obtained from
Imagene. Expression constructs of NF90 (residues 1–590
and residues 380–590) were cloned as N-terminal
hexahistidine-tagged fusion proteins into pETMCN (24).
Further C-terminal deletion constructs were made by
site-directed mutagenesis to add stop codons to the
NF90C591 construct. NF45 (residues 29–390) was
cloned into pGEX-6-p-1, with a N-terminal GST fusion
(GE Healthcare). For crystallization, NF90C381 and
NF45N28 were expressed separately in Escherichia coli
BL-21 Gold pLysS cells and co-lysed in 20mM Tris–HCl
pH 7.5, 500mM NaCl 1mM DTT. The complex was
puriﬁed in batch from cleared lysates using GSH resin
and eluted by overnight digestion with tobacco etch
virus (TEV) and 3C proteases. The protein was dialysed
into a low salt buffer (20mM Tris–HCl pH 7.5, 50mM
NaCl, 1mM DTT). Further puriﬁcation was carried out
using heparin sepharose with a salt gradient to 1000mM
NaCl, and size exclusion chromatography (20mM Tris–
HCl pH 7.5, 150mM NaCl, 1mM DTT).
Crystallization
The NF90C381/NF45N28 complex was concentrated
to 8mg/ml and crystallized by vapour diffusion in a sitting
drop with a reservoir solution of 100mM MES pH 6.0,
0.22M sodium malonate and 18% PEG 8000. Initial
crystals diffracted poorly and showed multiple lattices.
Crystals were improved using serial streak seeding.
Highly diffracting crystals grew in space group I222.
However many crystals were also found that grew in
related C2 space groups where one of the symmetry axes
of I222 had degenerated.
Data collection and structure solution
The crystals were cryoprotected in crystallization buffer
supplemented with 10% glycerol and ﬂash cooled to
100K in a liquid nitrogen cryostream. For phasing experi-
ments, the crystals were soaked for 1–2 h with K2AuCN4
prior to cryoprotection and cooling. Data were collected
at the X06SA beamline at the Swiss Light Source (Villigen,
Switzerland) using the PILATUS detector (25). The data
were indexed and integrated using XDS (26). The heavy
atom substructure was determined using SHELX (27) and
phases were improved using SHARP (28). Approximately
70% of the structure was completed by autobuilding with
BUCCANEER (29,30). Further building was carried out
manually using the graphics software COOT (31) and the
structure was further reﬁned against a higher resolution
native dataset with PHENIX (32). The ﬁnal statistics for
the geometry of the structure were calculated using
MOLPROBITY (33). Figures were prepared using
Pymol (The PyMOL Molecular Graphics System,
Version 1.3, Schro¨dinger, LLC).
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Nucleotide triphosphate soaking/co-crystallization and
data analysis
To overcome problems of dual occupancy of nucleotides
and malonate in the putative actives site of NF90N381/
NF45N28, the protein was rescreened for alternative
crystallization conditions. Crystals were grown in
12–14% PEG3350, 200mM MgCl2, 100mM MES pH
6.5 and 5% glycerol and were either soaked in a
cryoprotecant containing 10mM of the nucleotide tri-
phosphate (NTP) or co-crystallized in the presence of
10mM NTP. The crystals were cryoprotected in the crys-
tallization buffer supplemented with 20% glycerol and
ﬂash-cooled in liquid nitrogen to 100K. Data were col-
lected at beamlines I02 and I04-1 at Diamond Light
Source (Didcot, UK). As with native crystals, data from
NTP-bound crystals were indexed and integrated using
XDS (26). Crystals grown in PEG3350 grew either in
space group I222 with one molecule per asymmetric unit
or P21 with two molecules per asymmetric unit. Molecular
replacement using the native structure was carried out
with Phaser (30,34) followed by reﬁnement in PHENIX
(32) and model building with COOT (31). In the absence
of ligand, clear positive difference density was observed in
the Fo–Fc maps for the nucleotides. However during re-
ﬁnement after ﬁtting the ligands, negative Fo–Fc peaks
Figure 1. Overview of the NF90/NF45 DZF dimerization domain structure. (A) Schematic representation of the domain organization of NF45
(green) and NF90 (blue). Double-headed arrows underneath indicate the sub-fragments of each protein that were used for crystallization.
(B) Overview of the structure showing a ‘side’ view and a ‘top’ view rotated 90 around the horizontal axis. (C) Superposition of NF90 (blue)
on NF45 (gray) using the same orientations of NF45 as shown in B. Extensions at the N- and C-termini of NF45 that are involved in dimerization
interactions are shown in yellow. A C-terminal extension of NF90 is shown in magenta with a dotted line indicating a missing loop.
(D) Superposition of NF45 (grey) on yeast Poly (A) polymerase (PDBid 2q66, brown) and CCA-adding enzyme from Archaeoglobus fulgidis
(PDBid 1tfw, pink), shown from the ‘top’ view from (B).
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appeared suggesting that the ligands were not present at
full occupancy. The occupancy of the ligands was adjusted
manually to model the best ﬁt with the electron density
map and not reﬁned.
Co-immunoprecipitation
Sequences for human Zfr and SPNR were obtained as
cDNAs from Imagene. Vectors containing human
NF90b and NF45 cDNAs were a kind gift from S-E.
Behrens (Martin Luther University, Halle). Zfr, SPNR,
NF90b and NF45 were cloned into pEF-based mamma-
lian expression vectors (a kind gift from Elena Conti, MPI
Biochemistry, Martinsried) containing either an
N-terminal HA or an N-terminal HA-FLAG epitope
tag. Site-directed mutants were generated by PCR
amplification of the vector by Pfu Ultra polymerase
(Stratagene) with overlapping oligonucleotide primers
that encoded the mutation. Vector DNA was transiently
transfected into 293T cells in six-well plates (Iwaki)
growing in DMEM with foetal bovine serum and penicil-
lin/streptomycin (Gibco). An amount of 4 mg of vector
DNA was transfected using 6 ml lipofectamine 2000
(Invitrogen) in a total volume of 200 ml OptiMEM
(Gibco). The medium was replaced after 12 h and cells
were harvested after 36 h. The cells were placed on ice
and washed with 2ml PBS and then lysed by incubation
with 250 ml NET-G buffer (50mM Tris–HCl pH 7.5,
150mM NaCl, 0.1% NP40, 1mM EDTA, 10% glycerol,
protease inhibitor cocktail (Roche), 3U RNase A/T1 mix
(Fermentas) and 0.6 U RQ1 DNase (Promega)) for 15min
at 4C. The lysed cells were then resuspended from the
plates and centrifuged at 16 000 g for 15min at 4C to
remove insoluble debris. Ten percent of the soluble
fraction was removed for sodium dodecyl sulphate–poly-
acrylamide gel electrophoresis (SDS–PAGE) analysis
(input) while the remainder of the soluble fraction was
incubated with 15 ml a-FLAG resin with rotation at 4C
for 1 h. The samples were then washed three times in
NET-G buffer and excess liquid was removed with a
gel-loading tip. Proteins were eluted from the a-FLAG
resin by incubation with 3 FLAG peptide (0.2mg/ml
in NET-G) at 4C for 15min. Samples from input and
eluted proteins were separated by SDS–PAGE,
transferred onto a nitrocellulose membrane (Whatman)
and probed with a mouse a-HA antibody (Covance) at a
1:2500 dilution in 5% milk in PBS-T. After washing in
PBS-T, the blot was then probed with a secondary goat
a-mouse antibody (Biorad) at a dilution of 1:10 000 in 5%
milk/PBS-T. After washing off the secondary antibody,
the blot was visualized with Super West pico ECL
reagent (Pierce) and exposed to ﬁlm.
RESULTS
Structural studies
Structural studies were carried out with mouse NF90 and
NF45. Mouse and human NF90 show 95% sequence
identity while mouse and human NF45 are identical at
the protein level. Both NF90 and NF45 can be expressed
recombinantly in E. coli as soluble proteins. However,
attempts to purify the proteins separately were problem-
atic as NF45 showed a tendency to aggregate and precipi-
tate. Thermal denaturation studies of NF45 showed that it
has a melting temperature (Tm) of 25
C while a complex of
the DZF domains of NF90 and NF45 showed a Tm of
55C indicating that the presence of NF90 greatly
enhances the stability of NF45 (Supplementary Figure
S1). A co-lysis and co-puriﬁcation approach allowed a
1:1 complex of NF90/NF45 to be isolated that showed
no aggregation. Indeed, the complex is stable even in
high salt concentrations of 0.5M.
NF90 contains two dsRBDs that have previously been
shown to bind dsRNA (35,36). To assess the integrity of
the puriﬁed proteins, electrophoretic mobility shift assays
(EMSA) were carried out with both single-stranded (ss)
and double-stranded (ds) RNA substrates. A long con-
struct NF90C591/NF45 (which includes the DZF and
dsRBD domains of NF90 but not the C-terminal low
complexity region) and a fragment containing only the
dsRBDs of NF90 (residues 380–590) both showed
dsRNA-binding activity as expected. A shorter construct
containing only the DZF dimerization domains
(NF90C381/NF45N28) showed no mobility shift
with either ss or dsRNA indicating that this fragment is
not necessary for RNA binding (Supplementary Figure
S2). However, the long NF90C591/NF45 complex
shows qualitative differences compared with the dsRBD
construct: the long complex shows apparently tighter
binding and less heterogeneity than the dsRBDs alone.
This suggests that the DZF domain, while not required
for RNA binding, might nevertheless contribute to recog-
nition of RNA substrates.
Initial attempts to crystallize the NF90C591/NF45
construct were not successful, most likely because of the
multiple domains present in NF90. A series of C-terminal
truncations of NF90 were designed based on sequence
analysis and limited proteolysis. Expression trials
showed that NF90 constructs truncated beyond residue
380 were not soluble. Well-diffracting crystals were
obtained with complexes that contained residues 1–380
of NF90 and 29–390 of NF45. An overview of the
domain structure of NF90 and NF45 is shown in
Figure 1A, with the constructs used for crystallization
indicated underneath.
Phases for the structure were obtained using single
wavelength anomalous dispersion (SAD) from gold-
derivatized crystals that diffracted to 3.3 A˚. The structure
was reﬁned against a native dataset that diffracted to 1.9 A˚
with a Rwork=18.5% and Rfree=21.0% and good stereo-
chemistry (Table 1). The model includes 658 residues out
of a total of 741 that were present in the crystal. Residues
in the N- and C-termini and several loops (residues 1–5,
55–86, 341–353 and 375–380 of NF90 and 362–390 of
NF45) could not be modelled due to poor electron
density in these regions that made a clear interpretation
of the map difﬁcult.
The DZF dimerization domains of NF90 and NF45
form an oblong structure with a ﬂat face on one side
and a curved face on the other (Figure 1B). Each
protein shows a bipartite domain, characterized by an
N-terminal mixed a–b region that contains a central
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anti-parallel b-sheet and a C-terminal a-helical region
(Figures 1B and 2). NF90 and NF45 have 30% sequence
identity over the DZF domain and superpose with a root
mean square deviation (r.m.s.d.) of 2.0 A˚ over 261 residues
out of 334 (Figure 1C). This gives the overall structure a
pseudo 2-fold rotational symmetry. The central b-sheet of
each domain forms the base of a cleft between the N- and
C-terminal halves while dimerization of NF90 and NF45
is mediated by the a-helices at the C-terminus of each
protein. NF45 has an extension to the DZF domain at
the N-terminus, consisting of residues 29–47, that contrib-
utes to dimerization (see below). NF90 and NF45 also
differ at their C-termini: residues 354–374 of NF90 pack
in an extended conformation against the ﬂat side of NF90.
In contrast, residues 343–361 of NF45 follow a different
path, forming a short b-hairpin and then binding in an
extended conformation along the dimerization interface
(Figure 1C).
A structural similarity search using the DALI server
showed that the DZF domains of NF90 and NF45 have
signiﬁcant structural similarity to members of the
template-free nucleotidyltransferase family that includes
poly (A) polymerases, TUTases, 20–50 oligoadenylate
synthase and the CCA-adding enzymes of tRNAs
(Figure 1D and Supplementary Figure S3). Template-
free nucleotidyltransferases belong to the DNA polymer-
ase b family of nucleotidyltransferases (37,38). None of
the template-free nucleotidyltransferases for which struc-
tures are known encode dsRBDs for substrate recognition.
However both poly (A) polymerase and the CCA-adding
enzyme have RNA-binding domains in addition to their
catalytic domains that aid with substrate recognition or
processivity. The dsRBD domains of NF90 emanate from
the ﬂat side of the molecule, on the opposite face to that
observed in other template-free nucleotidyltransferases
(Supplementary Figure S3). However, the linker region
between the end of the visible C-terminus and the ﬁrst
dsRBD is 23 residues, which would be sufﬁcient to
allow the dsRBDs to access the same face of the
molecule as the auxiliary RNA-binding domains
observed in other template-free nucleotidyltransferases.
This family of enzymes catalyses the transfer of one
NTP to the end of an existing oligonucleotide substrate.
These enzymes have a catalytic signature sequence that
includes three negatively charged residues (in yeast poly
(A) polymerase, Pap1, these are residues Asp100, Asp102
and Asp154) at the base of the catalytic cleft, on the
exposed surface of the b-sheet (Figure 3A). These nega-
tively charged residues are required to position two
divalent metal ions (typically two Mg2+ ions or Mg2+
and Mn2+) that co-ordinate the close approach of the
phosphate groups of an incoming NTP to the substrate
RNA primer (Figure 3A). In addition to this catalytic
triad, a serine residue (Ser89 in Pap1) and a lysine
residue (Lys215) are conserved in the template free
nucleotidyltransferases and help to orient the g-phosphate
of the NTP.
Neither NF90 nor NF45 has a full complement of these
critical residues in their putative active sites. In NF45, two
of the characteristic negatively charged residues, equiva-
lent to Asp100 and Asp154, have been replaced with a
valine residue (Val119) and a lysine residue (Lys174), re-
spectively (Figure 3B). In NF90, the residue equivalent
to Asp154 is replaced by a threonine residue (Thr168,
Figure 3C). In addition, the serine and lysine residues at
the base of the nucleotide-binding site are replaced by a
leucine (Leu97) and an arginine residue (Arg234), respect-
ively (Figure 3C). The structural analysis strongly indi-
cates that the DZF domains of NF90 and NF45 are
unlikely to possess nucleotidyltransferase activity. We
further carried out an in vitro nucleotidyltransferase
assay using a-labelled ATP or UTP. Although activity
could be shown for a known poly (A) polymerase, no
activity was detectable for NF90/NF45 in the conditions
we used for this assay (Supplementary Figure S4)
Nucleotide binding to NF90/NF45
Although it is unlikely that NF90/NF45 could actually
catalyse nucleotidyl transfer, prominent cleft regions of
both NF90 and NF45 are conserved in both proteins
(Supplementary Figure S5) suggesting that this region of
the protein might nevertheless be functionally important.
Furthermore, a malonate ion from the crystallization
solution, which is negatively charged, was found in the
cleft of both NF90 and NF45 in approximately the
position where the triphosphate moiety of nucleotides is
bound in other template-free nucleotidyltransferases. This
suggested that NF90/NF45 might bind nucleotide ligands.
To identify potential nucleotide ligands, NF90C381/
NF45N28 crystals were soaked with ATP, UTP, CTP
and GTP. Initial data from soaking experiments showed
Table 1. Data collection, phasing and reﬁnement statistics for NF90/
NF45 native structure
Dataset Native AuCN derivative
Beamline Swiss light source PXII
Wavelength (A˚) 1.0077 1.0077
Spacegroup I 2 2 2 C2
Unit cell (A˚) a=82.9 a=229.9 a=90.00
b=131.3 a= b= g=90 b=83.4 b=127.1
c=176.0 c=133.0 g=90.00
Resolution range (A˚) 79.0–1.9 (2.0–1.9)a 81.0–3.3 (3.2–3.0)
Unique reﬂections 74596 76165
Multiplicity 6.4 3.4
Completeness (%) 98.4 (95.4) 99.0 (99.6)
I/s(I) 15.3 (3.4) 16.4 (6.7)
Rsym (%) 8.0 (60.6) 6.7 (20.2)
Reﬁnement
Rfree (%) 21.0
Rwork (%) 18.5
r.m.s.d. bonds (A˚) 0.007
r.m.s.d. angles () 1.03
B-factors (A˚2)
Overall 30.8
Protein 29.5
Solvent 38.4
Ramachandran values
Most favoured (%) 97.5
Allowed (%) 2.5
Disallowed (%) 0
aValues in parentheses are for the highest resolution shell.
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extra density in the cleft of NF45 that was overlapping but
larger than the electron density of the malonate ion. This
suggested that nucleotides were competing with malonate
ions for binding. An alternative crystallization form was
identiﬁed that grew with PEG3350 as a precipitant and did
not require sodium malonate. Crystals grown in PEG3350
belong either to I 222 or to P 21 space groups and diffract
to lower resolution than crystals grown in sodium
malonate. Several datasets of these crystals that were
either grown or soaked with different nucleotides were
collected and analysed (Table 2). Datasets from crystals
co-crystallized with ATP or soaked with UTP (at 2.7 and
2.8 A˚ resolution, respectively) showed clear electron
density for the ligand in the cleft of NF45. A dataset
where CTP was co-crystallized with the complex diffracted
to 3.1 A˚ resolution and also showed positive difference
density at the same site but the density for the nucleotide
was less well deﬁned. This could be because CTP binds less
Figure 2. Conservation of NF90 and NF45 sequences. (A) Multiple sequence alignment of NF45 with sequences from mouse (M.m) zebraﬁsh (D.r.)
Drosphila (D.m.) and Ciona intestinalis (C.i.). A structure-based alignment of NF45 with yeast poly (A) polymerase is shown underneath. Human
NF45 was not included as it has 100% identity with mouse NF45. Secondary structure elements are shown underneath as bars (a-helices) or arrows
(b-strands). Blue dots indicate residues that interact with NF90, pink dots indicate residues that interact with ATP and black boxes show residues
equivalent to those involved in catalysis in functional nucleotidyl transferases. Purple boxes indicate the two residues on helix 9 that were mutated to
disrupt dimer formation. (B) Sequence alignment of NF90 with sequences from mouse (M.m.), human (H.s.), zebraﬁsh (D.r.) and Xenopus (X.l.).
NF90 is only found in vertebrates. Green dots indicate residues that are involved in dimerization interaction with NF45.
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well to this site and so does not saturate the nucleotide-
binding sites in the crystal. Although a number of datasets
were collected from crystals grown in the presence of
GTP, none showed any evidence for nucleotide binding.
Thermal denaturation assays with NF45 and the various
nucleotides showed a similar trend: greater stabilization of
the protein was seen in the presence of ATP and UTP
(6–7C) while CTP and GTP showed a lesser degree of
stabilization (5C and 3C, respectively, Supplementary
Figure S6A).
In all of the datasets analysed, the electron density
was clearly interpretable for the triphosphate moiety of
the NTPs and a magnesium ion but less clear for
the bases. A similar effect has been noted in previous
studies with mitochondrial editosome-like complex
associated TUTase1 (MEAT1) and RNA editing
Figure 3. A close-up view of the active site of poly (A) polymerase and equivalent regions in NF90 and NF45. (A) The catalytic cleft of yeast poly
(A) polymerase (derived from PDBids 2q66 and 3c66) showing the catalytic residues and the bound ATP and a poly (A) substrate. (B) and (C) top
view of NF45 and NF90 oriented as in Figure 1C, looking into the cleft between the two domains. The residues shown are those in equivalent
positions to catalytic and nucleotide-binding residues found in related nucleotidyl transferases. (D) ATP bound to the cleft of NF45. A 2Fo–Fc map
from the ﬁnal reﬁned structure is shown, contoured at 1s. (E) and (F) A similar view as in (D) showing complexes with UTP and CTP, respectively.
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terminal uridylyltransferase 2 (RET2) where clear density
for the triphosphate moiety could be seen with non-
cognate NTPs but the bases remained poorly deﬁned
(39,40). The g phosphate of each of the NTPs makes a
close approach to Ser107 at the base of the cleft and is
further stabilized by Lys228 (Figure 3D–F). The Mg2+ ion
is co-ordinated by an oxygen atom of Asp121 and three
oxygen atoms from the a, b and g phosphates of the nu-
cleotide. The metal is also likely to be co-ordinated by
water molecules that were not visible at this resolution.
None of the datasets analysed showed any evidence for
nucleotide binding to the NF90 cleft. This is unlikely to be
because of inaccessibility of the cleft. This region of NF90
shows a similar exposure to solvent channels as the
equivalent region of NF45. The structural analysis
points to a crucial difference in the pocket between
NF90 and NF45, namely the presence of a leucine
residue, Leu97, at the base of the binding pocket. This
residue is found in the equivalent position to the conserved
serine, Ser107, which is present in NF45 and in functional
template-free nucleotidyltransferases. The proximity of
Leu97 to Arg234, which is normally a lysine residue in
other nucleotidyltransferases, may form a steric block
that prevents the triphosphate moiety from binding.
Surprisingly, when the binding mode of ATP, UTP and
CTP are compared in the three structures, the orientation
of the triphosphate moiety is retained while the positions
of the bases vary. The orientation of ATP in NF45 shows
remarkable similarity to ATP binding in Pap1. The
adenine base contacts the edges of His207 on helix 4,
which in turn is oriented by a pi-stacking interaction
with Trp243. The adenine moiety makes further van der
Waals interactions with the side chains of Thr241 and
Pro242 at the beginning of helix 6. The base of UTP
ﬂips over to make an alternative set of van der Waals
contacts with Leu176 on strand 5 and Ser200 and
Ala201 on helix 4. The cytosine base is placed in an inter-
mediate position and has van der Waals interactions with
His207, Ala203 and Ala204 of helix 4.
The binding of ATP and UTP with NF45 is something
of a puzzle. The binding site for these ligands is clearly
conserved and the position and orientation of the triphos-
phate moiety is similar to that observed in catalytically
active template-free nucleotidyltransferases. However,
the protein does not seem able to use the nucleotides to
catalyse nucleotidyl transfer and also shows little struc-
tural perturbation on nucleotide binding (r.m.s.d. values
between native and nucleotide-bound structures range
from 0.4 to 0.8 A˚). One possibility is that nucleotide
binding is an evolutionary relic. This would be analogous
to many pseudokinases of the serine/threonine protein
kinase family. In several cases, structural studies on
non-functional protein kinases have revealed that some
of these proteins retain the ability to bind ATP (41,42).
A more intriguing possibility is that nucleotide binding
might represent an as yet undeﬁned ligand such as a
peptide partner, a small molecule or an RNA-associated
chemical moiety.
The NF90/NF45 dimerization interface
The dimerization of NF90 and NF45 is mediated through
a close anti-parallel association of helix 9 and the inter-
action of the preceding loop region and C-terminal end of
helix 8 in each DZF domain. This interaction buries a
total area of 1698 A˚2, which is sufﬁcient for a biologically
relevant interaction (43). The helix 9 interface shows a
remarkable symmetry at its core with three conserved
residues on NF90 (Glu312, Gln319, Arg323) interacting
Table 2. Data collection and reﬁnement statistics for NF90C381/NF45N28 crystals with bound NTPs
Dataset (ligand) ATP UTP CTP
Beamline Diamond I04-1 Diamond I02 Diamond I04-1
Wavelength (A˚) 0.9173 0.9795 0.9173
Spacegroup P 1 21 1 I 2 2 2 P 1 21 1
Unit cell (A˚) a=70.9 a=90.00 a=83.9 a=90.00 a=71.16 a=90.00
b=84.1 b=93.34 b=133.5 b=90.00 b=83.97 b=93.57
c=159.6 g=90.00 c=178.0 g=90.00 c=159.68 g=90.00
Resolution range (A˚) 66.11–2.69 (2.84–2.69)a 66.76–2.80 (2.95–2.80) 66.43–3.10 (3.27–3.10)
Unique reﬂections 50 589 23 950 33 184
Multiplicity 2.9 4.2 2.8
Completeness (%) 97.1 (93.7)a 96.7 (95.4) 96.8 (98.7)
I/s(I) 8.0 (2.9) 10.1 (2.4) 7.6 (2.8)
Rsym (%) 10.1 (37.6) 13.1 (62.7) 12.5 (36.5)
Reﬁnement
Rfree (%) 26.6 26.3 25.3
Rwork (%) 24.0 23.6 21.5
r.m.s.d. bonds (A˚) 0.004 0.011 0.012
r.m.s.d. angles () 0.68 1.06 0.87
B-factors (A˚2)
Overall 37.0 49.1 39.8
Ligand 42.1 31.5 30.79
Ramachandran values
Most favoured (%) 95.5 95.5 94.7
Allowed (%) 4.2 4.3 4.6
Disallowed (%) 0.3 0.2 0.7
aValues in parentheses are for the highest resolution shell.
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with three similar conserved residues on NF45 (Asp308,
Gln315, Arg319) (Figure 4A). The glutamine residues
make a polar contact at the centre of the interaction
while the Arg323 from NF90 forms a salt bridge with
Asp308 of NF45, as does Arg319 of NF45 with Glu312
on NF90. From this interaction one can imagine how this
heterodimerization interface could have evolved from a
homodimeric precursor. The symmetry of the interaction
breaks down at either end of helix 9, with Phe327 at the
C-terminal end of helix 9 in NF90 contributing a hydro-
phobic interaction while His323 at the C-terminal end of
NF45 helix 9 and Arg308 and Gln309 at the N-terminal
end of NF90 helix 9 contribute to a more hydrophilic
interface (Figure 4A). Packed against the helix 9–helix 9
interface is an extended region of the C-terminus of NF45,
which makes primarily main chain interactions with
residues on both NF45 and NF90 and contributes a
tyrosine side chain (Tyr358) to the hydrophobic pocket
at the N-terminal end of NF45 helix 9.
NF45 has an N-terminal extension in addition to the
C-terminal extension that also contributes to the dimer-
ization interface (Figures 1C and 4B). The N-terminal ex-
tension of NF45 packs against the opposite face of the
molecule, on helix 8 and the loop region that connects it
to helix 9 (Figure 4B). Like the C-terminal extension, the
N-terminal extension of NF45 interacts with both NF90
and NF45 at the dimerization interface. However, unlike
the C-terminal extension, these interactions are primarily
mediated by side chain interactions that are contributed
by His29, Pro31, Phe32, Asp33, Phe34, Tyr35 and Phe41.
Figure 4. The NF90/NF45 dimerization interface. (A) Close up view of the dimerization interface in the same orientation as the top view in
Figure 1B. The C-terminal extension of NF45 (yellow) lies in an extended conformation over helix 9 (H9) of NF90 (blue) and NF45 (green).
Helix 9 shows symmetrical binding interactions at the core. Mutated residues in NF45 are marked with an asterisk. (B) A close up view of the
interface rotated 180 around the horizontal axis. The N-terminal extension of NF45 is shown in yellow. Conserved residues involved in the
dimerization interface and in stabilizing the N-terminal extension are shown. (C) A sequence alignment of the dimerization interface of mouse
NF90 with related DZF domain-containing proteins, SPNR and Zfr. Sequences from mouse (M.m.), zebraﬁsh (D.r.) Xenopus species (X.l. and X.t.)
and salmon (S.s.) are shown.
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Consequently, the N-terminal extension of NF45 buries a
large hydrophobic surface area that presumably contrib-
utes to stabilization of the complex. Additional polar
interactions are contributed by Asp33, which forms a
salt bridge with Arg270 on NF45, and His29, which
hydrogen bonds with Glu270 and Glu277 on NF90.
The contribution of the N- and C-terminal extensions of
NF45 to its interaction with NF90 lends asymmetry to the
interaction interface. It is unlikely that NF45 would be
able to homodimerize because the extension sequences
would likely cause a steric clash. Similarly, it also seems
unlikely that NF90 could homodimerize as the hydropho-
bic surface that is protected by the N-terminus of NF45
would be exposed. Interestingly, when NF90 is compared
with other DZF domain containing proteins such as
SPNR and Zfr, the residues involved in NF45 interactions
are relatively well conserved (Figure 3B). Based on these
observations, two predictions can be made: ﬁrst; that
NF90 and NF45 are unable to form homodimers and
second; that NF45 might be a binding partner for other
DZF domain-containing proteins, namely SPNR and Zfr.
Indeed, a TAP-tagging study of the binding partners of
the Drosophila homologue of Zfr, Zn72D, showed that it
co-puriﬁes with Drosophila NF45 (44).
To test whether NF90 and NF45 can homodimerize and
whether NF45 is a binding partner of other DZF-domain
containing proteins, a co-immunoprecipitation assay
using tagged human proteins in mammalian cells was set
up. For this assay isoform 6 of NF90, NF90b, was used.
Each protein was cloned as an N-terminally HA-FLAG or
HA tagged protein and pairs of differentially tagged con-
structs were co-transfected into 293T cells. Tagged
proteins were immunoprecipitated with anti-FLAG resin
and the presence of binding partners was examined by
anti-HA western blot (Figure 5). All experiments were
carried out in the presence of nucleases to remove RNA.
Control experiments showed that HA-tagged proteins do
not bind non-speciﬁcally to the anti-FLAG resin
(Figure 5B, lanes 1–3). Co-transfection of HA-NF45
with HA-FLAG NF45 did not show a complex form on
co-immunoprecipitation (Figure 5B, lane 4), conﬁrming
previous observations with in vitro pull down experiments
(45). Similarly HA-FLAG NF90 is unable to
co-precipitate HA-NF90. In this case, a C-terminally
truncated HA-FLAG-tagged mouse NF90C591 was
co-transfected with full-length NF90b to differentiate the
two constructs by size. This conﬁrms that neither NF45
nor NF90 are able to homodimerize.
NF45 forms alternative complexes with SPNR and Zfr
NF90 and NF45 show a robust co-precipitation in this
assay (Figure 5C, lane 1). To disrupt dimerization, a
double mutant of NF45 was created where the charges
were reversed on two of the residues forming the core
interaction on helix 9 i.e. Asp308 was mutated to
arginine (D308R) and Arg319 was mutated to glutamate
(R319E). Although the mutated protein is expressed in the
transfected cells, there is no association with NF90 in the
co-precipitation assay, showing that the mutant does
indeed disrupt binding to NF90 (Figure 5C, lane 2).
Similar co-immunoprecipitation reactions showed a
robust interaction between SPNR and NF45 (Figure 5C,
lanes 3 and 4) and between Zfr and NF45 (lane 6).
However, when either SPNR or Zfr were co-transfected
with the mutant NF45, no interaction could be seen (lanes
5 and 7). This demonstrates that NF45 can form
complexes with both Zfr and SPNR. The lack of inter-
action with the mutant shows that NF45 uses the same
interface to interact with Zfr and SPNR as it uses to
interact with NF90. The absence of an interaction with
the mutant is unlikely to be caused by a disruption to
the structural integrity of the mutant. Thermal denatur-
ation assays carried out with a puriﬁed NF45 mutant
showed that it has a similar melting proﬁle to the wild-
type protein and is also stabilized in the presence of UTP
and ATP (Supplementary Figure S6B).
Interestingly, in each case where NF90, SPNR and Zfr
are co-expressed with the mutant NF45, the overall
amount of protein expressed is lower than when functional
pairs are expressed together. This effect is seen consist-
ently over multiple experiments and so is unlikely to be
caused by variable expression levels that are normally seen
with transient transfections. It has previously been shown
that NF90 protein levels are correlated with NF45 levels
(46). Given the difference in stability of NF45 on its own
versus in a complex (Tm=25
C versus 55C) this differ-
ence in expression is likely to come from the mutual sta-
bilization effect of the two partner proteins.
DISCUSSION
The structural studies on the dimerization domain of
NF90 and NF45 show that these proteins belong to the
family of template-free nucleotidyltransferase enzymes.
However, the lack of conserved catalytic residues
suggests that the DZF domain encodes a
‘pseudotransferase’ that is no longer able to catalyse
transfer of nucleotides. Ligand-binding studies indicate
that NF45, but not NF90, retains the ability to bind
NTPs in a conserved binding pocket at the degenerated
active site. Whether NTPs are the true ligands of this site
remains to be established.
The co-precipitation studies conﬁrm two predictions
based on the structure of the NF90/NF45 complex. We
have demonstrated that NF45 is not able to homodimerize
in a cellular context. This is most likely because of the
intrinsic asymmetry of the dimerization interaction with
NF90, as well as the potential steric clashes with the N-
and C-terminal extensions of NF45. The second predic-
tion was based on the observation that residues in NF90
that are involved in binding are conserved in SPNR and
Zfr. The prediction that NF45 should interact with both
of these related proteins is borne out by the
co-precipitation studies and shows that the interaction
between Zfr and NF45 is present in mammals as well as
in ﬂies. Furthermore, this interaction is disrupted when
these proteins are co-transfected with NF45 that is
mutated at critical residues on helix 9, indicating that
NF90, SPNR and Zfr use a conserved interface for their
interaction with NF45.
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Figure 5. Co-immunoprecipitation studies of NF45 with other DZF domain-containing proteins. (A) Overview of domain organization of
DZF-domain containing proteins. (B) Co-immunoprecipitation studies carried out with HA-tagged proteins (1. HA-NF45, 2. HA-NF90, 3.
HA-STRBP) and with differentially tagged pairs of NF45 (lane 4) and NF90 (lane 5). (C) Co-immunoprecipitation studies of NF45 wild-type
(lanes 1, 3, 4 and 6) or NF45 mutant (lanes 2, 5 and 7) co-transfected with NF90 (lanes 1 and 2), SPNR (lanes 3,4 and 5) and Zfr (lanes 6 and 7).
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These interactions help to explain the evolutionary re-
lationship between NF90 and NF45. The DZF domains of
NF90 and NF45 share 30% sequence identity and a high
degree of structural similarity. The complex that the two
proteins form is very intimate and, based on our thermal
denaturation assays and previous in vivo observations
(46), NF45 is unstable in the absence of a binding
partner both in vitro and in vivo. Both NF45 and Zfr are
found in worms and insects and a Zfr-like protein that has
only one annotated zinc ﬁnger is found, along with NF45,
in early metazoans such as Trichoplax adherans and Ciona
intestinalis. NF90 and SPNR, on the other hand, are only
found in vertebrates. We would predict that NF45 is
always found in a complex with NF90, SPNR or Zfr/
Zfr-like proteins. It is also possible that some early
metazoa might have a symmetrical NF45 homodimer.
Indeed, the symmetrical interactions at the core of the
dimerization interface suggest that all of these complexes
might have arisen from a homodimeric precursor.
It is interesting that NF45, which retains a conserved
ligand-binding site, is also the component that is able to
participate in other protein complexes. That NF45 can
participate in a variety of different complexes also has
important implications for functional studies of all of
the DZF proteins. Both NF90 and Zfr are widely ex-
pressed in a variety of tissues and so NF90/NF45 and
Zfr/NF45 complexes could co-exist in the same cells.
SPNR shows a more restricted tissue distribution and is
found primarily in brain and testes. However both NF90
and Zfr are also present in neuronal cells, suggesting that
in this system there is an even richer variety of this family
of complexes present. Since levels of NF90 and NF45 are
known to be co-regulated, caution should be exercised
when overexpressing or knocking down individual
proteins as this could potentially lead to a redistribution
of other DZF domain complexes.
Further cell-based, biochemical and structural studies
are required to determine the functional role of the DZF
dimerization domain in its various different guises. The
dimer presents an extended protein surface that is highly
conserved (Supplementary Figure S5). This extended
surface could potentially provide a docking platform for
protein–protein interactions. Furthermore, although the
DZF domain is not required for dsRNA binding, it
might nevertheless contribute to RNA recognition, either
through the conserved ligand-binding site or through
sequence-speciﬁc interactions. Future studies will eluci-
date the role of this platform in the various biological
roles proposed for NF90 and NF45.
ACCESSION NUMBERS
Data have been deposited in the PDB with the following
accession codes: 4AT7, 4AT8, 4AT9 and 4ATB.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures 1–6 and Supplementary Methods.
ACKNOWLEDGEMENTS
The authors thank Elena Conti (MPI for Biochemistry,
Martinsried) for supporting the early part of this work.
The authors thank Doris Lindner for cloning of NF90
constructs and Katherina Nagel (Conti Department) for
supplying Gld2/Gld3 complex. The authors thank Fabien
Bonneau for constructive discussions and help with setting
up EMSA, nucleotidyltransferase and coIP assays. The
authors thank the crystallization facility at the MPI for
Biochemistry in Martinsried for initial crystallization
screening and beam-line scientists at the Swiss Light
Source and Diamond Light Source for support during
data collection. The authors thank the staff of the
Edinburgh Protein Production Facility and Biophysical
Core Facility for support with protein puriﬁcation and
characterization. The authors thank Elena Conti, Fulvia
Bono and Esben Lorentzen for critical reading of the
manuscript.
FUNDING
Medical Research Council [G1000520 to A.G.C.];
Wellcome Trust [077707, 092076] and the early part,
Max Planck Gesellschaft. Funding for open access
charge: Wellcome Trust [092076].
Conﬂict of interest statement. None declared.
REFERENCES
1. Marcoulatos,P., Koussidis,G., Mamuris,Z., Velissariou,V. and
Vamvakopoulos,N.C. (1996) Mapping interleukin enhancer
binding factor 2 gene (ILF2) to human chromosome 1 (1q11-qter
and 1p11-p12) by polymerase chain reaction ampliﬁcation of
human-rodent somatic cell hybrid DNA templates. J. Interferon
Cytokine Res., 16, 1035–1038.
2. Barber,G.N. (2009) The NFAR’s (nuclear factors associated with
dsRNA): evolutionarily conserved members of the dsRNA
binding protein family. RNA Biol., 6, 35–39.
3. Corthesy,B. and Kao,P.N. (1994) Puriﬁcation by DNA afﬁnity
chromatography of two polypeptides that contact the NF-AT
DNA binding site in the interleukin 2 promoter. J. Biol. Chem.,
269, 20682–20690.
4. Kao,P.N., Chen,L., Brock,G., Ng,J., Kenny,J., Smith,A.J. and
Corthesy,B. (1994) Cloning and expression of cyclosporin A- and
FK506-sensitive nuclear factor of activated T-cells: NF45 and
NF90. J. Biol. Chem., 269, 20691–20699.
5. Orford,R.L., Robinson,C., Haydon,J.M., Patient,R.K. and
Guille,M.J. (1998) The maternal CCAAT box transcription factor
which controls GATA-2 expression is novel and developmentally
regulated and contains a double-stranded-RNA-binding subunit.
Mol. Cell Biol., 18, 5557–5566.
6. Shamanna,R.A., Hoque,M., Lewis-Antes,A., Azzam,E.I.,
Lagunoff,D., Pe’ery,T. and Mathews,M.B. (2011) The NF90/
NF45 complex participates in DNA break repair via
nonhomologous end joining. Mol. Cell Biol., 31, 4832–4843.
7. Shi,L., Qiu,D., Zhao,G., Corthesy,B., Lees-Miller,S., Reeves,W.H.
and Kao,P.N. (2007) Dynamic binding of Ku80, Ku70 and NF90
to the IL-2 promoter in vivo in activated T-cells. Nucleic Acids
Res., 35, 2302–2310.
8. Reichman,T.W., Parrott,A.M., Fierro-Monti,I., Caron,D.J.,
Kao,P.N., Lee,C.G., Li,H. and Mathews,M.B. (2003) Selective
regulation of gene expression by nuclear factor 110, a member of
the NF90 family of double-stranded RNA-binding proteins. J.
Mol. Biol., 332, 85–98.
9. Xu,Y.H. and Grabowski,G.A. (1999) Molecular cloning and
characterization of a translational inhibitory protein that binds to
Nucleic Acids Research, 2012, Vol. 40, No. 18 9367
coding sequences of human acid beta-glucosidase and other
mRNAs. Mol. Genet. Metab., 68, 441–454.
10. Sakamoto,S., Aoki,K., Higuchi,T., Todaka,H., Morisawa,K.,
Tamaki,N., Hatano,E., Fukushima,A., Taniguchi,T. and Agata,Y.
(2009) The NF90-NF45 complex functions as a negative regulator
in the microRNA processing pathway. Mol. Cell Biol., 29,
3754–3769.
11. Kuwano,Y., Kim,H.H., Abdelmohsen,K., Pullmann,R. Jr.,
Martindale,J.L., Yang,X. and Gorospe,M. (2008) MKP-1 mRNA
stabilization and translational control by RNA-binding proteins
HuR and NF90. Mol. Cell Biol., 28, 4562–4575.
12. Kuwano,Y., Pullmann,R. Jr., Marasa,B.S., Abdelmohsen,K.,
Lee,E.K., Yang,X., Martindale,J.L., Zhan,M. and Gorospe,M.
(2010) NF90 selectively represses the translation of target mRNAs
bearing an AU-rich signature motif. Nucleic Acids Res., 38,
225–238.
13. Hoque,M., Shamanna,R.A., Guan,D., Pe’ery,T. and
Mathews,M.B. (2011) HIV-1 replication and latency are regulated
by translational control of cyclin T1. J. Mol. Biol., 410, 917–932.
14. Neplioueva,V., Dobrikova,E.Y., Mukherjee,N., Keene,J.D. and
Gromeier,M. (2010) Tissue type-speciﬁc expression of the
dsRNA-binding protein 76 and genome-wide elucidation of its
target mRNAs. PLoS One, 5, e11710.
15. Shim,J., Lim,H., R.Yates,J. and Karin,M. (2002) Nuclear export
of NF90 is required for interleukin-2 mRNA stabilization. Mol.
Cell, 10, 1331–1344.
16. Isken,O., Grassmann,C.W., Sarisky,R.T., Kann,M., Zhang,S.,
Grosse,F., Kao,P.N. and Behrens,S.E. (2003) Members of the
NF90/NFAR protein group are involved in the life cycle of a
positive-strand RNA virus. EMBO J., 22, 5655–5665.
17. Isken,O., Grassmann,C.W., Yu,H. and Behrens,S.E. (2004)
Complex signals in the genomic 3’ nontranslated region of bovine
viral diarrhea virus coordinate translation and replication of the
viral RNA. RNA, 10, 1637–1652.
18. Isken,O., Baroth,M., Grassmann,C.W., Weinlich,S.,
Ostareck,D.H., Ostareck-Lederer,A. and Behrens,S.E. (2007)
Nuclear factors are involved in hepatitis C virus RNA replication.
RNA, 13, 1675–1692.
19. Gomila,R.C., Martin,G.W. and Gehrke,L. (2011) NF90 binds the
dengue virus RNA 3’ terminus and is a positive regulator of
dengue virus replication. PLoS One, 6, e16687.
20. Parrott,A.M. and Mathews,M.B. (2007) Novel rapidly evolving
hominid RNAs bind nuclear factor 90 and display
tissue-restricted distribution. Nucleic Acids Res., 35, 6249–6258.
21. Shi,L., Zhao,G., Qiu,D., Godfrey,W.R., Vogel,H., Rando,T.A.,
Hu,H. and Kao,P.N. (2005) NF90 regulates cell cycle exit and
terminal myogenic differentiation by direct binding to the 3’-
untranslated region of MyoD and p21WAF1/CIP1 mRNAs. J.
Biol. Chem., 280, 18981–18989.
22. Zhao,G., Shi,L., Qiu,D., Hu,H. and Kao,P.N. (2005) NF45/ILF2
tissue expression, promoter analysis, and interleukin-2
transactivating function. Exp. Cell Res., 305, 312–323.
23. Duchange,N., Pidoux,J., Camus,E. and Sauvaget,D. (2000)
Alternative splicing in the human interleukin enhancer binding
factor 3 (ILF3) gene. Gene, 261, 345–353.
24. Diebold,M.L., Fribourg,S., Koch,M., Metzger,T. and Romier,C.
(2011) Deciphering correct strategies for multiprotein complex
assembly by co-expression: application to complexes as large as
the histone octamer. J. Struct. Biol., 175, 178–188.
25. Kraft,P., Bergamaschi,A., Broennimann,C., Dinapoli,R.,
Eikenberry,E.F., Henrich,B., Johnson,I., Mozzanica,A.,
Schleputz,C.M., Willmott,P.R. et al. (2009) Performance of
single-photon-counting PILATUS detector modules. J.
Synchrotron. Radiat., 16, 368–375.
26. Kabsch,W. (2010) Xds. Acta Crystallogr. D Biol. Crystallogr., 66,
125–132.
27. Sheldrick,G.M. (2008) A short history of SHELX. Acta
Crystallogr. A, 64, 112–122.
28. Bricogne,G., Vonrhein,C., Flensburg,C., Schiltz,M. and
Paciorek,W. (2003) Generation, representation and ﬂow of phase
information in structure determination: recent developments in
and around SHARP 2.0. Acta Crystallogr. D Biol. Crystallogr.,
59, 2023–2030.
29. Cowtan,K. (2006) The Buccaneer software for automated model
building. 1. Tracing protein chains. Acta Crystallogr. D Biol.
Crystallogr., 62, 1002–1011.
30. Collaborative computing project, n. (1994) The CCP4 suite:
programs for protein crystallography. Acta Crystallogr. D Biol.
Crystallogr., 50, 760–763.
31. Emsley,P. and Cowtan,K. (2004) Coot: model-building tools for
molecular graphics. Acta Crystallogr. D Biol. Crystallogr., 60,
2126–2132.
32. Adams,P.D., Afonine,P.V., Bunkoczi,G., Chen,V.B., Davis,I.W.,
Echols,N., Headd,J.J., Hung,L.W., Kapral,G.J., Grosse-
Kunstleve,R.W. et al. (2010) PHENIX: a comprehensive
Python-based system for macromolecular structure solution. Acta
Crystallogr. D Biol. Crystallogr., 66, 213–221.
33. Chen,V.B., Arendall,W.B. 3rd, Headd,J.J., Keedy,D.A.,
Immormino,R.M., Kapral,G.J., Murray,L.W., Richardson,J.S.
and Richardson,D.C. (2010) MolProbity: all-atom structure
validation for macromolecular crystallography. Acta Crystallogr.
D Biol. Crystallogr., 66, 12–21.
34. McCoy,A.J., Grosse-Kunstleve,R.W., Adams,P.D., Winn,M.D.,
Storoni,L.C. and Read,R.J. (2007) Phaser crystallographic
software. J. Appl. Crystallogr., 40, 658–674.
35. Scarlett,G.P., Elgar,S.J., Cary,P.D., Noble,A.M., Orford,R.L.,
Kneale,G.G. and Guille,M.J. (2004) Intact RNA-binding domains
are necessary for structure-speciﬁc DNA binding and
transcription control by CBTF122 during Xenopus development.
J. Biol. Chem., 279, 52447–52455.
36. Liao,H.J., Kobayashi,R. and Mathews,M.B. (1998) Activities of
adenovirus virus-associated RNAs: puriﬁcation and
characterization of RNA binding proteins. Proc. Natl Acad. Sci.
USA, 95, 8514–8519.
37. Holm,L. and Sander,C. (1995) DNA polymerase beta belongs to
an ancient nucleotidyltransferase superfamily. Trends Biochem.
Sci., 20, 345–347.
38. Yue,D., Maizels,N. and Weiner,A.M. (1996) CCA-adding
enzymes and poly(A) polymerases are all members of the same
nucleotidyltransferase superfamily: characterization of the
CCA-adding enzyme from the archaeal hyperthermophile
Sulfolobus shibatae. RNA, 2, 895–908.
39. Deng,J., Ernst,N.L., Turley,S., Stuart,K.D. and Hol,W.G. (2005)
Structural basis for UTP speciﬁcity of RNA editing TUTases
from Trypanosoma brucei. EMBO J., 24, 4007–4017.
40. Stagno,J., Aphasizheva,I., Bruystens,J., Luecke,H. and
Aphasizhev,R. (2010) Structure of the mitochondrial
editosome-like complex associated TUTase 1 reveals divergent
mechanisms of UTP selection and domain organization. J. Mol.
Biol., 399, 464–475.
41. Fukuda,K., Gupta,S., Chen,K., Wu,C. and Qin,J. (2009) The
pseudoactive site of ILK is essential for its binding to
alpha-Parvin and localization to focal adhesions. Mol. Cell, 36,
819–830.
42. Zeqiraj,E., Filippi,B.M., Goldie,S., Navratilova,I., Boudeau,J.,
Deak,M., Alessi,D.R. and van Aalten,D.M. (2009) ATP and
MO25alpha regulate the conformational state of the
STRADalpha pseudokinase and activation of the LKB1 tumour
suppressor. PLoS Biol., 7, e1000126.
43. Lo Conte,L., Chothia,C. and Janin,J. (1999) The atomic structure
of protein-protein recognition sites. J. Mol. Biol., 285, 2177–2198.
44. Worringer,K.A., Chu,F. and Panning,B. (2009) The zinc ﬁnger
protein Zn72D and DEAD box helicase Belle interact and control
maleless mRNA and protein levels. BMC Mol. Biol., 10, 33.
45. Parker,L.M., Fierro-Monti,I., Reichman,T.W., Gunnery,S. and
Mathews,M.B. (2001) Double-stranded RNA-binding proteins and
the control of protein synthesis and cell growth. Cold Spring
Harb. Symp. Quant. Biol., 66, 485–497.
46. Guan,D., Altan-Bonnet,N., Parrott,A.M., Arrigo,C.J., Li,Q.,
Khaleduzzaman,M., Li,H., Lee,C.G., Pe’ery,T. and Mathews,M.B.
(2008) Nuclear factor 45 (NF45) is a regulatory subunit of
complexes with NF90/110 involved in mitotic control. Mol. Cell
Biol., 28, 4629–4641.
9368 Nucleic Acids Research, 2012, Vol. 40, No. 18
